Explore Related Events:
Introducing the Cell Therapies Event Series, a collection of 26 established events curated to enable this community to achieve their clinical and commercial potential.
Download the Partnership Prospectus to see:
26 Events
in the
Series
Bespoke Partnerships Opportunities
Audience
Breakdown
Creative Branding
Options
Establish Your Brand as the Go-To as Cell Therapies Rapidly Expand into the Autoimmune Space
With many cell therapy leaders entering the clinic this year looking to accelerate their candidates through to commercialization, now was the time to elevate your solutions at the 2nd Cell Therapy for Autoimmune Disease Summit. Partners had exclusive access to the needs and challenges key stakeholders in this space face allowing them to fill these gaps and forge lasting partnerships. They met C-level executives, directors, and VPs from top cell therapy companies expanding into the autoimmune space including Cartesian Therapeutics, Novartis, Cabaletta Bio, and Bristol Myers Squibb to establish their presence in this explosive field.
Next year, showcase your expertise in this summit through podium presentations, moderating panel discussions, and hosting roundtables to put the spotlight on your dedicated solutions.
Experts Need Your Help With:
Product Manufacturing: Scaling manufacturing of cell therapy products in a GMP-compliant facility including cell, protein, and antigen
manufacturing
GLP/GMP Compliant Translational Studies: providing appropriate animal models, expertise in animal handling and testing to best recapitulate autoimmune disease pre-clinically
Assay Development, Qualification and Validation: Expertise in designing, optimizing, and validating assays for product characterization and potency determination
Media and Reagent Provision: appropriate and high-quality tissue, blood, and culture media provision. Procurement of cell therapy laboratory reagents
Instrumentation: Sensitive and cutting-edge instruments including bioreactors, automated flow cytometry, ddPCR, and more
Regulatory Guidance: Assistance in navigating complex regulatory requirements and ensuring compliance from IND-IMPD through to BLA and commercialization
Gene Engineering: Provision of editing components including viral vectors, proteins, and plasmids. Expertise in engineering autologous therapies
Why Partner In 2025?
1
Spotlight your dedicated solutions to an engaged and tight-knit audience ensuring you make intimate connections and accelerate partnerships.
2
Build relationships with senior decision makers and stakeholders to drive your commercial and strategic goals with your focused target audience.
Who Did Partners Meet In 2024?
Showcase your expertise in this summit